Investor /Strategic Partner
AMENDED AND RESTATED FINANCIAL AND INVESTOR RELATIONS AGREEMENT
This Agreement is dated effective as of June 28 , 2010.
HELIX BIOPHARMA CORP. having an office at
3-305 Industrial Parkway South, Aurora, Ontario, Canada
(hereinafter referred to as “Helix” or the “Company”)
ACM ALPHA CONSULTING MANAGEMENT EST. having an office at
St. Markusgasse 27 a, FL – 9490 Vaduz
(hereinafter referred to as “ACM”)
WHEREAS Helix previously retained ACM to provide Helix with investor and financial advisory services in
Europe, by execution of the Financial and Investor Relations Agreement dated as of January 25, 2010
(hereinafter referred to as the “Original Agreement”); and
WHEREAS ACM has experience in investor and financial advisory matters in Europe and has previously
provided such services to Helix; and
WHEREAS Helix and ACM desire to enter into a new agreement modifying or supplementing the provisions of
the Original Agreement.
NOW THEREFORE in consideration of the sum of One Dollar now paid by each party to the other, and other
good and valuable consideration, the receipt and adequacy of which are hereby acknowledged by the parties, the
parties hereby covenant and agree as follows:
When used in this agreement the following words and expressions shall have the following meanings:
“ U.S. Securities Act ”; shall mean the United States Securities Act of 1933, as amended.
“ Distribution Compliance Period ”; shall mean the period beginning when the Securities were first offered to
an ACM Contacted Investor or the date of the closing of the final Placement, whichever is later, and ending forty
(40) days after such date.
“ Distributor ”; shall mean any underwriter, dealer (as defined under Section 2(a)(12) of the U.S. Securities
Act), or other person who participates, pursuant to a contractual arrangement, in the distribution of the Securities
offered or sold in relianc